Publication | Open Access

Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentImmunologyHpiv3-seronegative Young ChildrenVirologyInfection ControlMedicineVaccine ResearchVirus Vaccine Rhpiv3cp45